Q2 2016

Filed Aug 17, 2016 · 10-Q · 48 days after period end · 0001121781-16-000515

Q2 2016 · 10-Q

Revenue—

Net Income

-$1.88M

N/M vs Q2 2015

EPS Diluted

-$52.95

N/M vs Q2 2015

Gross Profit$96,000N/M

Operating Income-$898,000N/M

Same quarter

Metric	Q2 2016	Q2 2015	Q2 2014	Q2 2013
Revenue	—	$10.00K	$11.00K	$222.00K
Net Income	-$1.88M	-$1.71M	-$2.15M	-$1.75M
EPS Diluted	-$52.95	-$0.03	-$0.03	-$0.04

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR